Friday, August 31, 2018

CLINICAL PHARMACY CONGRESS 2019

About Conference


Conference Series LLC Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently, we are bringing forth “5th Annual Congress on Clinical & Hospital Pharmacy” (Clinical Pharmacy Congress 2019) scheduled to be held on April 25-26, 2019 at Tokyo, Japan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceuticals and Clinical Research.

In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of clinical research, hospital pharmacy, method development and validation by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Hospital and Clinical Pharmacy.
Target Audience:
  • Experts in Clinical Pharmacy and Pharmacology
  • Research Heads from Research Center's
  • Pharmacists and Pharmacy Technicians from various areas
  • Eminent Scientific Professionals in Pharma
  • Pharmaceutical Associations and Societies
  • Clinical trial experts in Pharmaceutical and Life science
  • Pharmaceutical Business Entrepreneurs
  • Manufacturing Pharmaceutical products Companies
  • Physicians, Nurses, and Clinical Practitioner
  • Noble laureates in Health Care and Medicine
  • Directors of clinical laboratories department in various Universities and institutions
  • Marketing teams of Industries with novel products to showcase at the conference
  • Directors and Professors from Universities and Institutions
  • Post-doctoral and Ph.D. students working on clinical pharmacy and hospital pharmacy program
  • Relevant Graduate and Postgraduate students

Conference Highlights



Special Issues


  • All accepted abstracts will be published in OMICS International respective Journals.
  • Abstracts will be provided with Digital Object Identifier by CrossRef

No comments:

Post a Comment